Glynova-M1 Tablet Tablet SR
Manufacturer
Tycoon Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Key Information
Short Description
Glynova-M1 Tablet Tablet SR is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Dosage Form
Tablet SR
Introduction
Glynova-M1 Tablet Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glynova-M1 Tablet Tablet SR is to be taken with food.
Safety Information
Side Effects
It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
Alcohol Warning
It is unsafe to consume alcohol with Glynova-M1 Tablet Tablet SR.
Breastfeeding Warning
Glynova-M1 Tablet Tablet SR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy Warning
Glynova-M1 Tablet Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Glynova-M1 Tablet Tablet SR is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
Quick Tips
Monitor your blood sugar level regularly while you are taking this medicine. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting and stomach pain as Glynova-M1 Tablet Tablet SR may cause a rare but serious condition called lactic acidosis which is an excess of lactic acid in the blood.
Related Medicines
Isryl-M 1 Tablet
Geniride-M 1 Tablet SR
Vopril M 1mg/500mg Tablet SR
Moses M 1mg/500mg Tablet SR
Justmet-GP 1mg/500mg Tablet SR
Glytylus M 1mg/500mg Tablet SR
Rossmet G 1mg/500mg Tablet SR
Glimtune M 1mg/500mg Tablet SR
Metgreat-G1 Tablet SR
Mgcor 1 Tablet SR
Frequently asked questions
What are the recommended storage conditions for Glynova-M1 Tablet Tablet SR?
Keep this medicine in its original container or pack, tightly closed. Store it according to the instructions mentioned on the pack or label. Do not allow pets, children, or other people to access the medication.
Can the use of Glynova-M1 Tablet Tablet SR lead to lactic acidosis?
Yes, using Glynova-M1 Tablet Tablet SR can potentially lead to lactic acidosis. It is a rare but serious side effect that is caused by an increase in lactic acid levels in the blood. This condition is often referred to as MALA (Metformin-associated lactic acidosis). It's important to note that this side effect can be triggered by using metformin and therefore may pose a risk for those with pre-existing conditions such as kidney disease, elderly individuals, or heavy alcohol consumers. If you suspect lactic acidosis, please seek immediate medical attention. Symptoms include muscle pain or weakness, dizziness, feelings of fatigue or cold in the arms and legs, difficulty breathing, nausea, vomiting, stomach pain, or slow heart rate. If these symptoms occur, stop taking Glynova-M1 Tablet Tablet SR immediately and consult your doctor.
What is Glynova-M1 Tablet Tablet SR?
Glynova-M1 Tablet Tablet SR is a combination of two medicines: Glimepiride and Metformin. This medication is used to treat type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when taken alongside proper diet and regular exercise. Glimepiride lowers blood sugar by increasing insulin release from the pancreas, while Metformin works by reducing glucose production in the liver and improving insulin sensitivity. This combination is not suitable for treating type 1 DM.
What are the possible side effects of Glynova-M1 Tablet Tablet SR?
While Glynova-M1 Tablet Tablet SR is generally safe, it can cause common side effects like hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, and headache. It is important to monitor for these side effects, as they may indicate a need for adjustments in dosage or administration.
Can the use of Glynova-M1 Tablet Tablet SR lead to Vitamin B12 deficiency?
Yes, long-term use of Glynova-M1 Tablet Tablet SR can potentially cause vitamin B12 deficiency. This happens because it interferes with the absorption of Vitamin B12 in the stomach. If left untreated, it may lead to anemia and nerve problems and could result in tingling sensations and numbness in hands and feet, weakness, urinary problems, changes in mental status, and difficulty maintaining balance (ataxia). To avoid these potential issues, consider supplemental intake of vitamin B12 from external sources at least once per year.
Can the use of Glynova-M1 Tablet Tablet SR cause hypoglycemia?
Yes, using Glynova-M1 Tablet Tablet SR can cause hypoglycemia (low blood sugar level). This often occurs when you miss or delay meals, consume alcohol, over-exercise, or take other antidiabetic medications concurrently with it. Therefore, regular blood glucose monitoring is crucial. Keep a readily available source of sugar like glucose tablets, honey, or fruit juice at all times.
Is it safe to take alcohol while I am also taking Glynova-M1 Tablet Tablet SR?
No, it is not safe to consume alcohol alongside Glynova-M1 Tablet Tablet SR. This combination can lower blood sugar levels and increase the risk of hypoglycemia, as well as potentially triggering lactic acidosis.
